Nektar Therapeutics – NKTR – FDA Approval of OMONTYS
Nektar Therapeutics (NASDAQ: NKTR) today reported that its partner Affymax, Inc. announced that theU.S. Food and Drug Administration(FDA) has approved OMONTYS® (peginesatide) Injection for the treatment of anemia due to chronic kidney disease (CKD)...